EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

The role of astaxanthin‐Cu2+ in stabilizing glycated human serum albumin for type 2 diabetes mellitus management: a computational approach

Naufal Abiyyu, Alfia Fitrianita, I Made Artika, Josephine Elizabeth Siregar, Syahputra Wibowo, Bantari Wisynu Kusuma Wardhani, Canggih Setya Budi, Tri Rini Nuringtyas

Indonesian Journal of Biotechnology · 2026

DOI: 10.22146/ijbiotech.109830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indonesian Journal of Biotechnology, 2026. Verfasst von Naufal Abiyyu und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes mellitus (T2DM) leads to the non‐enzymatic glycation of proteins, resulting in the formation of advanced glycation end products (AGEs), which contribute to diabetic complications. Human serum albumin (HSA), a major plasma protein, undergoes structural alterations upon glycation (gHSA), reducing its stability and biological functions. Astaxanthin (ASX), a potent antioxidant, is limited by its instability and moderate binding affinity. In this study, we explore the use of copper (Cu2+) to form a stable ASX‐Cu2+ complex, enhancing the antioxidant properties of ASX and improving its interaction with HSA and gHSA. Utilizing computational approaches such as molecular docking, molecular dynamics (MD) simulations, and free energy landscape (FEL) mapping, we analyze the stability and conformational changes of HSA and gHSA upon binding with ASX and ASX‐Cu2+. The residue interaction network (RIN) analysis reveals that ASX‐Cu2+ complexes create a more robust and interconnected network of non‐covalent interactions, particularly enhancing hydrogen bonding, π‐stacking, and ionic interactions. The ASX‐Cu2+ complex at a 1:2 molar ratio significantly improved the binding affinity and structural stability of both native and glycated HSA, reducing protein fluctuations and promoting a more compact conformation. These findings suggest that ASX‐Cu2+ complexes offer therapeutic potential for stabilizing albumin under glycation‐induced stress, with implications for managing oxidative stress and diabetes‐related complications.

Zitieren

APA

Abiyyu, N., Fitrianita, A., Artika, I. M., Siregar, J. E., Wibowo, S., Wardhani, B. W. K., Budi, C. S., & Nuringtyas, T. R. (2026). The role of astaxanthin‐Cu2+ in stabilizing glycated human serum albumin for type 2 diabetes mellitus management: a computational approach. Indonesian Journal of Biotechnology. https://doi.org/10.22146/ijbiotech.109830

Vancouver

Abiyyu N, Fitrianita A, Artika IM, Siregar JE, Wibowo S, Wardhani BWK, et al. The role of astaxanthin‐Cu2+ in stabilizing glycated human serum albumin for type 2 diabetes mellitus management: a computational approach. Indonesian Journal of Biotechnology. 2026. doi:10.22146/ijbiotech.109830

BibTeX
@article{Abiyyu2026,
  author = {Abiyyu, Naufal and Fitrianita, Alfia and Artika, I Made and Siregar, Josephine Elizabeth and Wibowo, Syahputra and Wardhani, Bantari Wisynu Kusuma and Budi, Canggih Setya and Nuringtyas, Tri Rini},
  title = {The role of astaxanthin‐Cu2+ in stabilizing glycated human serum albumin for type 2 diabetes mellitus management: a computational approach},
  journal = {Indonesian Journal of Biotechnology},
  year = {2026},
  doi = {10.22146/ijbiotech.109830}
}
Kostenlos starten →